Expand NAMS Menu
NAMS MENU

NAMS Latest Press Releases

-- November 3, 2026 --

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in November Globe Newswire 8:00 AM

-- October 2, 2026 --

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- September 29, 2026 --

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer's Disease Globe Newswire 8:00 AM

-- September 21, 2026 --

NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo (Obicetrapib Monotherapy) and Evlarco (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) Globe Newswire 9:00 AM

-- September 3, 2026 --

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:07 PM

-- September 2, 2026 --

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in September Globe Newswire 8:00 AM

-- August 26, 2026 --

NewAmsterdam Pharma Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026 Globe Newswire 8:00 AM

-- August 6, 2026 --

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- August 5, 2026 --

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results Globe Newswire 7:00 AM

-- July 29, 2026 --

NewAmsterdam Pharma to Host Investor Day on August 5, 2026 Globe Newswire 8:00 AM

-- July 24, 2026 --

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo (Obicetrapib Monotherapy) and Evlarco (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) Globe Newswire 8:00 AM

-- July 15, 2026 --

Attovia Therapeutics Appoints John W. Smither to Board of Directors Globe Newswire 8:30 AM

-- July 2, 2026 --

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- July 1, 2026 --

NewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026 Globe Newswire 8:00 AM

-- June 3, 2026 --

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes